Carcinoma in situ of skin
Chapter 2:Neoplasms
ICD-10 D04 is a billable code used to indicate a diagnosis of carcinoma in situ of skin.
Carcinoma in situ of the skin refers to a localized form of skin cancer where abnormal cells are present in the outer layer of the skin (epidermis) but have not invaded deeper tissues or spread to other parts of the body. This condition is often detected through skin examinations and can manifest as various types of lesions, including squamous cell carcinoma in situ (SCCIS) and basal cell carcinoma in situ (BCCIS). The lesions may appear as scaly patches, non-healing sores, or raised bumps. Early detection and treatment are crucial, as untreated carcinoma in situ can progress to invasive cancer. Treatment options typically include surgical excision, cryotherapy, topical chemotherapy, or photodynamic therapy. Regular surveillance is essential for patients diagnosed with carcinoma in situ, as they are at increased risk for developing subsequent skin cancers. The prognosis is generally favorable with appropriate management, but ongoing monitoring is recommended to prevent progression and recurrence.
Detailed descriptions of lesions, treatment modalities, and follow-up plans.
Diagnosis of carcinoma in situ during routine skin checks, treatment of lesions via excision or topical therapies.
Ensure accurate coding of the specific type of carcinoma in situ and any associated procedures.
Comprehensive treatment plans, including surgical notes and follow-up care.
Management of patients with multiple skin lesions and history of skin cancer.
Focus on the patient's overall cancer history and risk factors for recurrence.
Used when a biopsy is performed to confirm carcinoma in situ.
Document the site, size, and type of biopsy performed.
Dermatology and oncology specialties should ensure accurate coding based on the biopsy results.
Used for treatment of carcinoma in situ lesions.
Document the method of destruction and the size of the lesion.
Ensure that the treatment aligns with the diagnosis for proper billing.
Carcinoma in situ refers to cancer cells that are localized and have not invaded surrounding tissues, while invasive carcinoma has spread beyond the original site into deeper tissues.
Patients should undergo regular skin examinations, typically every 6 to 12 months, depending on individual risk factors and treatment history.
